[go: up one dir, main page]

IL162406A0 - Deuterated substituted dihydrofuranones and medicaments containing these compounds - Google Patents

Deuterated substituted dihydrofuranones and medicaments containing these compounds

Info

Publication number
IL162406A0
IL162406A0 IL16240602A IL16240602A IL162406A0 IL 162406 A0 IL162406 A0 IL 162406A0 IL 16240602 A IL16240602 A IL 16240602A IL 16240602 A IL16240602 A IL 16240602A IL 162406 A0 IL162406 A0 IL 162406A0
Authority
IL
Israel
Prior art keywords
compounds
medicaments containing
deuterated substituted
substituted dihydrofuranones
dihydrofuranones
Prior art date
Application number
IL16240602A
Other languages
English (en)
Original Assignee
Turicum Drug Dev Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Turicum Drug Dev Ag filed Critical Turicum Drug Dev Ag
Publication of IL162406A0 publication Critical patent/IL162406A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
IL16240602A 2001-12-12 2002-12-11 Deuterated substituted dihydrofuranones and medicaments containing these compounds IL162406A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10162120A DE10162120A1 (de) 2001-12-12 2001-12-12 Deuterierte substituierte Dihydrofuranone sowie diese Verbindungen enthaltende Arzneimittel
PCT/DE2002/004591 WO2003050101A1 (fr) 2001-12-12 2002-12-11 Dihydrofuranones substituees deuterees et medicaments contenant ces composes

Publications (1)

Publication Number Publication Date
IL162406A0 true IL162406A0 (en) 2005-11-20

Family

ID=7709639

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16240602A IL162406A0 (en) 2001-12-12 2002-12-11 Deuterated substituted dihydrofuranones and medicaments containing these compounds

Country Status (16)

Country Link
US (1) US7317039B2 (fr)
EP (1) EP1456192A1 (fr)
JP (1) JP2005511742A (fr)
KR (1) KR20040088474A (fr)
CN (1) CN1602304A (fr)
AU (1) AU2002360900A1 (fr)
CA (1) CA2469519A1 (fr)
DE (1) DE10162120A1 (fr)
HU (1) HUP0402304A2 (fr)
IL (1) IL162406A0 (fr)
IS (1) IS7267A (fr)
NO (1) NO20042907L (fr)
NZ (1) NZ533596A (fr)
PL (1) PL369139A1 (fr)
RU (1) RU2004121032A (fr)
WO (1) WO2003050101A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601737B2 (en) * 2005-07-26 2009-10-13 Nycomed Gmbh Isotopically substituted proton pump inhibitors
CA2653262A1 (fr) * 2006-05-26 2007-12-06 Auspex Pharmaceuticals, Inc. Preparation et utilisation de composes substitues a base d'acide carboxylique
WO2008070619A1 (fr) * 2006-12-04 2008-06-12 Auspex Pharmaceuticals, Inc. Préparation et utilité d'oxazolidinones substituées
US20080299216A1 (en) * 2007-06-01 2008-12-04 Protia, Llc Deuterium-enriched aripiprazole
US20090209608A1 (en) * 2007-08-29 2009-08-20 Protia, Llc Deuterium-enriched asenapine
US20090062185A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched anidulafungin
US20090069219A1 (en) * 2007-09-09 2009-03-12 Protia, Llc Deuterium-enriched telavancin
US20090076158A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched bicalutamide
US20090075870A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched caspofungin
US20090082419A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched tegaserod
MX2011000637A (es) 2008-07-15 2011-05-02 Theracos Inc Derivados deuretados de bencilbenceno y metodos de uso.
US20100120756A1 (en) * 2008-09-17 2010-05-13 Auspex Pharmaceuticals, Inc. Phenothiazine modulators of h1 receptors
WO2010056741A2 (fr) * 2008-11-12 2010-05-20 Auspex Pharmaceuticals, Inc. Inhibiteurs de cyclooxygénase à base d'acide phénylacétique
WO2010138889A1 (fr) * 2009-05-28 2010-12-02 Concert Pharmaceuticals, Inc. Peptides destinés au traitement des infections par le vhc
EP2488503A1 (fr) 2009-10-12 2012-08-22 Myrexis, Inc. Composés d'amino-pyrimidine en tant qu'inhibiteurs de tbkl et ou d'ikk epsilon
WO2011153157A2 (fr) * 2010-06-01 2011-12-08 Auspex Pharmaceutical, Inc. Inhibiteurs benzoquinolone de vmat2
EP3105232B1 (fr) 2014-02-10 2019-08-28 Concert Pharmaceuticals Inc. Triazolobenzodiazépines substituées
US9884872B2 (en) * 2014-06-20 2018-02-06 Intra-Cellular Therapies, Inc. Organic compounds
BR112020018669A2 (pt) * 2018-03-21 2020-12-29 Izumi Technology, Llc Análogos deuterados de elacridar
JP7612672B2 (ja) 2019-09-03 2025-01-14 イントラ－セルラー・セラピーズ・インコーポレイテッド 新規化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors

Also Published As

Publication number Publication date
DE10162120A1 (de) 2003-06-18
JP2005511742A (ja) 2005-04-28
EP1456192A1 (fr) 2004-09-15
US20050176814A1 (en) 2005-08-11
IS7267A (is) 2004-05-17
NO20042907L (no) 2004-07-09
CA2469519A1 (fr) 2003-06-19
US7317039B2 (en) 2008-01-08
RU2004121032A (ru) 2006-01-10
KR20040088474A (ko) 2004-10-16
AU2002360900A1 (en) 2003-06-23
NZ533596A (en) 2005-07-29
HUP0402304A2 (hu) 2005-02-28
PL369139A1 (en) 2005-04-18
CN1602304A (zh) 2005-03-30
WO2003050101A1 (fr) 2003-06-19

Similar Documents

Publication Publication Date Title
PL370563A1 (en) Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds
GB0112834D0 (en) Medicaments
AU2002365120A8 (en) Medicaments
HUP0401333A3 (en) Spiropyrazole compounds and pharmaceutical compositions containing them
AU2002257562A1 (en) Deuterated 3-Piperidinopropiophenone and medicaments containing said compounds
IL162406A0 (en) Deuterated substituted dihydrofuranones and medicaments containing these compounds
EP1398040A4 (fr) Composition de medicament
GB0128415D0 (en) Medicaments
GB0102902D0 (en) Medicaments
AP2003002783A0 (en) Medicament containing activted antihtrombin iii
IL161790A0 (en) Deuterated pyrazolopyrimidinones and drugs containing said compounds
GB0114746D0 (en) Medicinal composition
GB0105469D0 (en) Medicaments
GB0024517D0 (en) Use of medicaments
GB0130785D0 (en) Medicaments and novel compounds
GB0130679D0 (en) Medicaments and novel compounds
GB0130678D0 (en) Medicaments and novel compounds
GB0115182D0 (en) Medicaments
GB0122201D0 (en) Medicinal compounds
GB0126997D0 (en) Medicinal Compounds
GB0105741D0 (en) Medicinal compounds
GB0105740D0 (en) Medicinal compounds
GB0127024D0 (en) Medicinal compounds
GB0109028D0 (en) Medicaments
GB0129056D0 (en) Medicaments